• Report SKU:SKU: HVR3462
  • Description
  • Table of Contents
  • Request Sample

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2016 to 2027 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: ●  Market Sizing estimations and forecasts across the given market segments ●  Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, ) ●  Strategic recommendations in key business segments based on the market estimations ●  Regional and country level market analysis ●  Competitive landscaping of major market players ●  Company profiling covering the financials, recent activities and the future strategies

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 DNA Vaccines Market by Technology
5.1 Introduction
5.2 Plasmid DNA Vaccine Technology
5.2.1 Therapeutic Technology
5.2.2 Preventive Technology
5.3 Plasmid DNA Delivery Technology
5.3.1 Bacteriophages
5.3.2 Bacterial ghosts
5.3.3 Uncomplexed Plasmid DNA
5.3.4 Liposomes
5.3.5 Nanoparticles
5.3.6 Viruses
5.3.7 Gold Particles
5.3.8 Electroporation

6 DNA Vaccines Market by Type
6.1 Introduction
6.2 Human DNA Vaccines
6.3 Animal DNA Vaccines

7 DNA Vaccines Market by Application
7.1 Introduction
7.2 Human Diseases
7.2.1 Oncology
7.2.1.1 Pancreatic Cancer
7.2.1.2 Breast Cancer
7.2.1.3 Ovarian Cancer
7.2.1.4 Small Cell Lung Cancer
7.2.1.5 Melanoma
7.2.2 Allergies
7.2.3 Infectious Disease
7.2.3.1 Cytomegalovirus (CMV)
7.2.3.2 Hepatitis B (HBV)
7.2.3.3 Hepatitis C (HCV)
7.2.3.4 Human Immunodeficiency Virus (HIV)
7.2.3.5 Influenza
7.3 Veterinary Diseases
7.3.1 Equine West Nile Virus
7.3.2 Canine Melanom
7.3.3 Leishmaniasis

8 DNA Vaccines Market by End User
8.1 Introduction
8.2 Human Health
8.3 Research Application
8.4 Animal Health

9 DNA Vaccines Market by Product
9.1 Introduction
9.2 Recombinant Protein Vaccines
9.3 Genetic Vaccines

10 DNA Vaccines Market by Therapeutic Indication
10.1 Introduction
10.2 Cancer
10.3 Vector Borne Disease

11 Geographical Segmentation
11.1 North America
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 UK
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia Pacific
11.3.1 Japan
11.3.2 China
11.3.3 India
11.3.4 Australia
11.3.5 New Zealand
11.3.6 Rest of Asia Pacific
11.4 South America
11.4.1 Argentina
11.4.2 Brazil
11.4.3 Venezuela
11.4.4 Chile
11.4.5 Peru
11.5 Middle East & Africa
11.5.1 UAE
11.5.2 Saudi Arabia
11.5.3 Qatar
11.5.4 Iran
11.5.5 South Africa
11.5.6 Rest of Middle East & Africa

12 Vendor Landscaping
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiles
13.1 Bharat Biotech
13.2 Green Cross Corporation
13.3 Dendreon Corporation
13.4 Innovio Biomedical Corporation
13.5 Astellas Pharma
13.6 Indian Immunologicals Limited
13.7 Glaxosmithkline Inc.
13.8 MERCK and CO.
13.9 Ge Healthcare Life Sciences
13.10 Immunomic Therapeutics
13.11 Protein Sciences Corporation
13.12 Pfizer Pharmaceuticals
13.13 Novartis International AG
13.14 Sanofi
13.15 Zoetis
13.16 Serum Institute of India Pvt. Ltd
13.17 Eli Lilly and Company
13.18 Eurogentec S.A.
13.19 Madison Vaccines Incorporated (Mvi)
13.20 Merial Limited (Acquired by Boehringer Ingelheim)

14 Appendix

15 Disclaimer

List of Tables
Table 1 Global DNA Vaccines Market Analysis, by Region (2019-2027) ($MN)
Table 2 Global DNA Vaccines Market Analysis, by Technology (2019-2027) ($MN)
Table 3 Global DNA Vaccines Market Analysis, by Plasmid DNA Vaccine Technology (2019-2027) ($MN)
Table 4 Global DNA Vaccines Market Analysis, by Therapeutic Technology (2019-2027) ($MN)
Table 5 Global DNA Vaccines Market Analysis, by Preventive Technology (2019-2027) ($MN)
Table 6 Global DNA Vaccines Market Analysis, by Plasmid DNA Delivery Technology (2019-2027) ($MN)
Table 7 Global DNA Vaccines Market Analysis, by Bacteriophages (2019-2027) ($MN)
Table 8 Global DNA Vaccines Market Analysis, by Bacterial ghosts (2019-2027) ($MN)
Table 9 Global DNA Vaccines Market Analysis, by Uncomplexed Plasmid DNA (2019-2027) ($MN)
Table 10 Global DNA Vaccines Market Analysis, by Liposomes (2019-2027) ($MN)
Table 11 Global DNA Vaccines Market Analysis, by Nanoparticles (2019-2027) ($MN)
Table 12 Global DNA Vaccines Market Analysis, by Viruses (2019-2027) ($MN)
Table 13 Global DNA Vaccines Market Analysis, by Gold Particles (2019-2027) ($MN)
Table 14 Global DNA Vaccines Market Analysis, by Electroporation (2019-2027) ($MN)
Table 15 Global DNA Vaccines Market Analysis, by Type (2019-2027) ($MN)
Table 16 Global DNA Vaccines Market Analysis, by Human DNA Vaccines (2019-2027) ($MN)
Table 17 Global DNA Vaccines Market Analysis, by Animal DNA Vaccines (2019-2027) ($MN)
Table 18 Global DNA Vaccines Market Analysis, by Application (2019-2027) ($MN)
Table 19 Global DNA Vaccines Market Analysis, by Human Diseases (2019-2027) ($MN)
Table 20 Global DNA Vaccines Market Analysis, by Oncology (2019-2027) ($MN)
Table 21 Global DNA Vaccines Market Analysis, by Allergies (2019-2027) ($MN)
Table 22 Global DNA Vaccines Market Analysis, by Infectious Disease (2019-2027) ($MN)
Table 23 Global DNA Vaccines Market Analysis, by Veterinary Diseases (2019-2027) ($MN)
Table 24 Global DNA Vaccines Market Analysis, by Equine West Nile Virus (2019-2027) ($MN)
Table 25 Global DNA Vaccines Market Analysis, by Canine Melanom (2019-2027) ($MN)
Table 26 Global DNA Vaccines Market Analysis, by Leishmaniasis (2019-2027) ($MN)
Table 27 Global DNA Vaccines Market Analysis, by End User (2019-2027) ($MN)
Table 28 Global DNA Vaccines Market Analysis, by Human Health (2019-2027) ($MN)
Table 29 Global DNA Vaccines Market Analysis, by Research Application (2019-2027) ($MN)
Table 30 Global DNA Vaccines Market Analysis, by Animal Health (2019-2027) ($MN)
Table 31 Global DNA Vaccines Market Analysis, by Product (2019-2027) ($MN)
Table 32 Global DNA Vaccines Market Analysis, by Recombinant Protein Vaccines (2019-2027) ($MN)
Table 33 Global DNA Vaccines Market Analysis, by Genetic Vaccines (2019-2027) ($MN)
Table 34 Global DNA Vaccines Market Analysis, by Therapeutic Indication (2019-2027) ($MN)
Table 35 Global DNA Vaccines Market Analysis, by Cancer (2019-2027) ($MN)
Table 36 Global DNA Vaccines Market Analysis, by Vector Borne Disease (2019-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.